Arrowhead Pharmaceuticals reports Phase 2 study data of Zodasiran in patients with hyperlipidemia

Press/Media

Period30 May 2024

Media coverage

1

Media coverage

  • TitleArrowhead Pharmaceuticals reports Phase 2 study data of Zodasiran in patients with hyperlipidemia
    Media name/outletImpact Financial News
    Country/TerritoryUnited Kingdom
    Date30/05/24
    PersonsRobert Sidney Rosenson